130 related articles for article (PubMed ID: 36314458)
21. [Prostatic urothelial location of a tumor of the bladder].
Coulange C; Lechevallier E; de Fromont M
Prog Urol; 1997 Feb; 7(1):128-31. PubMed ID: 9116731
[TBL] [Abstract][Full Text] [Related]
22. Delayed diagnosis of prostate cancer with neuroendocrine differentiation after laser TURP.
Meeks JJ; Habermacher GM; Le B; Smith ND
Urology; 2008 Oct; 72(4):948.e11-2. PubMed ID: 18342929
[TBL] [Abstract][Full Text] [Related]
23. Prostatic ductal adenocarcinoma: a mini review.
Epstein JI
Med Princ Pract; 2010; 19(1):82-5. PubMed ID: 19996627
[TBL] [Abstract][Full Text] [Related]
24. Loss of high-molecular-weight cytokeratin antigenicity in prostate tissue obtained by transurethral resections.
Multhaupt HA; Fessler JN; Warhol MJ
Arch Pathol Lab Med; 2000 Dec; 124(12):1764-7. PubMed ID: 11100054
[TBL] [Abstract][Full Text] [Related]
25. Incidentally Detected Adenocarcinoma Prostate in Transurethral Resection of Prostate Specimens: a Hospital Based Study from India.
Varghese J; Kuruvilla PM; Mehta N; Rathore RS; Babu M; Bansal D; Pillai B; Sam MP; Krishnamorthy H
Asian Pac J Cancer Prev; 2016; 17(4):2255-8. PubMed ID: 27221926
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis of prostate adenocarcinoma using transurethral resection of the prostate after multiple negative transrectal biopsies and persistently elevated prostate-specific antigen level.
Vanasupa BP; Miller TA; Schwartz BF
Urology; 2000 Dec; 56(6):1056. PubMed ID: 11113765
[TBL] [Abstract][Full Text] [Related]
27. [Pathology and Pathophysiology of BPH and Relevant Incidental Findings in TUR-P].
Becker J; Moch H
Ther Umsch; 2023 Apr; 80(3):147-157. PubMed ID: 36975029
[TBL] [Abstract][Full Text] [Related]
28. Artifactual changes mimicking signet ring cell carcinoma in transurethral prostatectomy specimens.
Alguacil-Garcia A
Am J Surg Pathol; 1986 Nov; 10(11):795-800. PubMed ID: 2430479
[TBL] [Abstract][Full Text] [Related]
29. ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin.
Williamson SR; Zhang S; Yao JL; Huang J; Lopez-Beltran A; Shen S; Osunkoya AO; MacLennan GT; Montironi R; Cheng L
Mod Pathol; 2011 Aug; 24(8):1120-7. PubMed ID: 21499238
[TBL] [Abstract][Full Text] [Related]
30. Clear cell urothelial carcinoma of the urinary bladder: a case report and review of the literature.
Knez VM; Barrow W; Lucia MS; Wilson S; La Rosa FG
J Med Case Rep; 2014 Aug; 8():275. PubMed ID: 25124389
[TBL] [Abstract][Full Text] [Related]
31. Prostatic adenocarcinoma with atrophic features: malignancy mimicking a benign process.
Egan AJ; Lopez-Beltran A; Bostwick DG
Am J Surg Pathol; 1997 Aug; 21(8):931-5. PubMed ID: 9255256
[TBL] [Abstract][Full Text] [Related]
32. A novel resectoscope for transurethral resection of bladder tumors and the prostate.
Pantuck AJ; Baniel J; Kirkali Z; Klatte T; Zomorodian N; Yossepowitch O; Belldegrun AS
J Urol; 2007 Dec; 178(6):2331-6; discussion 2336. PubMed ID: 17936809
[TBL] [Abstract][Full Text] [Related]
33. First clinical experience with new transurethral bipolar prostate electrosurgery resection system: controlled tissue ablation (coblation technology).
Patel A; Adshead JM
J Endourol; 2004 Dec; 18(10):959-64. PubMed ID: 15801362
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer.
Shah RB; Zhou M; LeBlanc M; Snyder M; Rubin MA
Am J Surg Pathol; 2002 Sep; 26(9):1161-8. PubMed ID: 12218572
[TBL] [Abstract][Full Text] [Related]
35. Mucin-producing urothelial-type adenocarcinoma of prostate: report of two cases of a rare and diagnostically challenging entity.
Curtis MW; Evans AJ; Srigley JR
Mod Pathol; 2005 Apr; 18(4):585-90. PubMed ID: 15778694
[TBL] [Abstract][Full Text] [Related]
36. Florid hyperplasia of mesonephric remnants involving prostate and periprostatic tissue. Possible confusion with adenocarcinoma.
Gikas PW; Del Buono EA; Epstein JI
Am J Surg Pathol; 1993 May; 17(5):454-60. PubMed ID: 7682379
[TBL] [Abstract][Full Text] [Related]
37. [Benign mimickers of prostatic carcinoma on needle biopsy and transurethral resection specimens].
Zhao M; Li C; Teng X
Zhonghua Bing Li Xue Za Zhi; 2014 Nov; 43(11):781-5. PubMed ID: 25582263
[No Abstract] [Full Text] [Related]
38. Orthotopic bladder substitutes: histopathologic risk factors.
Nabeeh A; Gomha M; Shaaban AA; el-Baz M; el-Dosoky I; Ashamallah A; Ghoneim MA
Scand J Urol Nephrol; 1995 Dec; 29(4):463-7. PubMed ID: 8719364
[TBL] [Abstract][Full Text] [Related]
39. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical profile of high-grade urothelial bladder carcinoma and prostate adenocarcinoma.
Mhawech P; Uchida T; Pelte MF
Hum Pathol; 2002 Nov; 33(11):1136-40. PubMed ID: 12454820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
